The results of our study, the limited genetic evidence, and the conflicting data from biochemical studies in sporadic PD patient tissue emphasise the need for further clarification of the possible role of ACMSD as a possible PD risk gene and of the importance of the kynurenine pathway in the pathogenesis of PD. The gene discussed is ACMSD; the disease is Parkinson disease.